The synthesis and export of triacylglycerol (TAG) by the liver provides mammals with an efficient means of transporting a powerful source of energy either for storage in adipose tissue or for utilization, predominantly by muscle tissue. On a molar basis, the transport of large quantities of energy as TAG may be achieved at relatively low concentrations of TAG in the blood plasma. Similar amounts of energy, if present in other forms such as glucose, fatty acids, or ketone bodies, would require much higher concentrations of fuel and would give rise to considerable metabolic difficulties. Unfortunately, one of the inevitable consequences of concentrating biological energy to the extent which occurs in TAG is hydrophobicity and it is this property which, in itself, would prevent the smooth transport of TAG in the aqueous medium of the blood plasma. Overcoming the problem of hydrophobicity is part of the price which the higher animals pay for the many advantages inherent in the utilization of energy-rich TAG as a source of fuel [I] and is achieved by the intracellular assembly of spherical particles of very-low-density lipoprotein (VLDL). During this process hepatic TAG is adapted for life in an aqueous environment by encasing it in a hydrophilic mantle consisting of a monolayer of phospholipid and non-esterified cholesterol. The creation of a particle of VLDL from these intracellular lipids occurs at the very point at which they acquire a single molecule of apolipoprotein B (apoB) (for reviews, see [2,3]). This is a polypeptide containing 4536 residues and which, although hydrophobic in itself, somehow provides the structural framework required for the intracellular encapsulation of TAG within a hydrophilic lipid shell ( Figure 1 ). All these events occur at the aqueous interface which represents the boundary between the membrane and the lumen of the secretory apparatus of the cell. We are reasonably sure that VLDL particles begin life during the process of translation and translocation of apoB across the endoplasmic reticulum (ER) membrane, during which the conformational stability of apoB is Abbreviations used: apoB, apolipoprotein B; ER, endoplasmic reticulum; NEFA, non-esterified fatty acid; PL, phospholipid; TAG, triacylglycerol; VLDL, very-lowdensity lipoprotein.
ensured by its association with the inner leaflet of membrane phospholipids [4, 5] . This leaflet then collapses to form the outer monolayer of the VLDI, surface shell (Figure 1 ). Whether these particles reach their adult size at this location, however, or whether they pass their adolescence, growing larger as they acquire more TAG, in some other part of the secretory apparatus of the cell is, as yet, not known with any certainty and remains controversial [6-lo] .
Central to these issues is the means by which cellular TAG enters the core of the incipient VLDL particle. Several lines of evidence suggest that this is not simply a passive process of TAG accumulation within the membrane, as implied by Figure 1 ; rather that this scheme represents only a static snapshot of 
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a far more dynamic metabolic process with potential for the regulation, not only of VLDL output, but for hepatic lipid metabolism as a whole [ I l l . The purpose of the current paper, therefore, is to present these findings, and to discuss their implications for the control of hepatic lipid balance in terms of fatty acid storage, secretion and oxidation.
The metabolic route by which fatty acids enter VLDL TAG [18] [19] [20] . Time-course studies suggest, however, that TAG synthesized from this source is not utilized immediately for the assembly of VLDL particles but, initially, passes into a temporary storage pool, probably located in the cytosol of the cell [ 11, 171 . This represents the immediate and direct source of VLDL TAG. The exact means by which TAG is recruited from this pool to meet the requirements for VLDL assembly and secretion are not known. What is clear, however, is that cytosolic TAG is not transferred 'en bloc' as intact molecules into nascent VLDL particles. Instead, at some stage during the assembly of VLDL, possibly during transfer of TAG across the ER membrane, the molecules of cytosolic TAG undergo lipolysis followed by re-esterification of the resulting fatty acids [Zl-231. We know that at least 70% of the TAG secreted by rat liver is recruited via this lipolysidre-esterification cycle [23] . The nature of the lipase involved in the cycle is currently unknown as is its exact location within the cell. Since it is not inhibited by chloroquin, it is probably not the lysosoma1 acid lipase [23] . Also, its resistance to inhibition by insulin suggests that it is not a hormone-sensitive lipase similar to that which occurs in adipose tissue. Other, more circumstantial evidence, also makes hepatic lipoprotein lipase an unlikely candidate [23] . Regardless of its nature, the lipase responsible for the cycle is capable of generating far more fatty acid from stored TAG than is required to meet the needs of VLDI, assembly. The remaining fatty acids are simply re-esterified and returned back to the storage pool [23] . This observation does not necessarily imply, however, that the lipase has no potential regulatory significance and at least two instances are known in which low rates of lipolysis are associated with decreased rates of TAG secretion (see below).
Regulatory implications
The positive relationship commonly observed between extracellular NEFA levels and rates of hepatic TAG secretion observed in studies in vitro [24, 25] and, especially, in HepG2 cells [26] has, in some ways, been misleading in the sense that it implies that the plasma NEFA level is invariably a physiological regulator of hepatic VLDL output in vim. That this is clearly not the case is apparent from the many pathophysiological states in which plasma NEFA levels do not correlate with VLDL output. These include insulin-dependent diabetes [ 271, suckling [28] , and high fat consumption [29, 30] . Utilization of cytosolic TAG, rather than plasma free fatty acid (FFA), as the direct source of VLDL provides a buffer through which VLDL secretion rates may, in the short-term, be controlled independently of plasma NEFA levels.
With some exceptions, notably in those states associated with insulin resistance, at the whole body level elevated concentrations of plasma NEFA correlate more positively with ketogenesis than with hepatic VLDL output. This raises the interesting question as to whether both extracellular NEFA and fatty acids produced by intrahepatic TAG lipolysis are both equally capable of acting as substrates for oxidation or whether the hepatocyte discriminates between them, in some way, for this purpose. In this respect, our time-course studies of hepatic lipid balance in cultured hepatocytes have shown that rates of ketogenesis are high only when there is an elevated concentration of NEFA in the medium of the cells. The presence of a large quantity of intracellular TAG is not sufficient, in itself, to maintain a high rate of fatty acid oxidation [ 171. This is not a new finding and similar observations were made several years ago by Heimberg's group [31] using the perfused liver model. Neither are fatty acids released by lipolysis of intracellular TAG an efficient source of substrate for oxidation. Thus, as mentioned above, although about three times more fatty acids are released by this process than are required for VLDL assembly [23] , the excess fatty acids are not available for oxidation since, during . It would appear, therefore, that in the normal adult rat intrahepatic lipid metabolism is compartmentalized in such a way as to ensure that intracellular TAG is utilized almost exclusively for VLDL assembly and that ketogenesis relies predominantly upon the availability of an extracellular fatty acid pool. This arrangement would add another tier to the longestablished reciprocal regulation of fatty acid oxidation and esterification which is, of course, the major theme of the present colloquium. The final question relating to the regulatory implications of VLDL TAG recruitment is whether the lipolysis/re-esterification cycle involved may provide a regulatory focus for the control of hepatic VLDL output. This question remains to be answered. However, two observations suggest that this step might be considered as a serious candidate for metabolic control. First, tolbutamide inhibits both VLDL secretion and intrahepatic TAG lipolysis [23] . Secondly, in the human hepatoma cell line HepG2 which secretes little TAG, overall intracellular TAG lipolysis is very low compared with that which occurs in normal rat hepatocytes [32] .
The indirect route for recruitment of VLDL TAG described in Figure 2 predicts at least two dis-
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Figure 2
The metabolic route through which fatty acids are recruited for the assembly of VLDL Extracellular fatty acids are esterified at Site I on the cytosolic surface of the ER. The product TAG is transferred mainly into the cell cytosol. Cytosolic TAG is recruited for VLDL TAG assembly via lipolysis followed by re-esterification of the product fatty acid at Site 2 in the ER.
VLDL
CELL CYTOSOL
Extracellular FFA tinct intracellular sites for fatty acid esterification. Site 1 is responsible for the esterification of extracellular fatty acids which are then transferred mainly to the cell cytosol. Site 2 represents the location at which fatty acids released by intracellular lipolysis are re-esterified and, in some way, made available for transfer into the lumen of the ER for VLDL assembly. Experimental evidence for dual intracellular sites of TAG synthesis comes from the kinetic studies of Kondrup et al. [33] and, more recently, from the discovery of the presence of two distinct sites of diacylglycerol acyltransferase activity in the microsomal fraction of liver cells [ 341.
It is possible that the exact physical location of one of these sites (Site 1) within the cell is associated with a part of the microsomal membrane which is in close physical contact with mitochondria [35] . This represents a pre-Golgi fraction of the cell secretory apparatus with a very high capacity for fatty acid esterification. The product TAG is transferred to the cellular storage pool, rather than into VLDL [36] . Incidentally, the presence of such a mitochondrial-microsomal complex within the cell raises the interesting question as to whether this may represent a single physical intracellular site responsible for tight regulation of the reciprocal coupling of fatty acid metabolism in which extracellular fatty acids are channelled either into the esterification pathway on the one hand, or the oxidative pathway on the other.
The metabolic role of phospholipids in the assembly of VLDL
During the course of some of the studies described above, it became clear that, in the absence of extracellular fatty acids, the amount of VLDL TAG secreted by hepatocytes over a period of time was greater than could be accounted for by the loss of TAG from the cell (Table 1) . Furthermore, measurements of the specific radioactivity of intracellular and VLDL TAG synthesized in the presence of extracellular [ 'Hloleate suggested that oleate alone could by no means account for all the TAG synthesized by the cell (Table 1) . S' ince we have previously shown that, in cultured hepatocytes, fatty acids and TAG synthesized de novo contribute only a small fraction of the cellular and secreted TAG [32] , it became obvious that an alternative metabolic source contributed a considerable proportion of the cellular and VLDL TAG fatty acids. The only cellular source large enough to make such a contribution is phospholipid. What follows below is a brief summary of some of the experiments designed to test this hypothesis. First, in experiments in which cellular phospholipid (PL) was prelabelled with [3H] oleate, the loss of labelled PL from the cell was much greater than that which could be accounted for by the secretion of labelled PL with VLDL. Little or no PL was secreted into fractions of density greater than 1.006g/ml. Secondly, drugs such as tolbutamide and chloroquin, both of which inhibit the secretion of VLDL, also prevented the loss of cellular, prelabelled PL. Thirdly, in pulse-chase experiments in which glycerolipids were labelled with a pulse of trace amounts of [3H]oleate of high specific activity, followed by a 'chase' with 0.75 mM oleate, there was little net loss of cellular TAG label despite the appearance of large quantities of labelled VLDL TAG in the cell medium. This labelled secreted TAG could be accounted for almost entirely by the loss of labelled PL from the cell. Despite this, there was little or no loss of PL mass, indicating a rapid turnover of cellular PL during the secretion of VLDL TAG. Fourthly, the secretion of VLDL could be inhibited in the presence of inhibitors of phospholipase A, such as p-bromophenacyl bromide at concentrations which were non-toxic to the cell (D. Wiggins, unpublished work). Fifthly, during culture of cells in which membrane phospholipids had been prelabelled specifically with [ I4C] dipalmitoylphosphatidylcholine, about 14% of the cellular phospholipid label appeared in the medium associated with VLDL TAG [ 113.
At present, it is impossible to be certain as to whether membrane PL fatty acids are transferred directly into VLDL TAG or whether they initially become part of the cellular pool of the TAG from which VLDL TAG is derived by the processes described above. In this context, however, the results of the following experiment may be of relevance. Cytosol was isolated from cells in which the cytoplasmic TAG pool had been prelabelled in situ by incubating the cells in the presence of C3H]oleate. When this TAG-labelled cytosolic fraction was incubated with hepatic microsomal membranes Volume 23 derived from a different donor animal, there was a time-dependent transfer of fatty acids from the cytosolic TAG to the microsomal membrane PL [ 1 13. The initial quantities of labelled NEFA and PL in the cytosolic fraction were insignificant and unable to account for the amount of PL label in the microsomal membrane.
It would appear, therefore, that cells have the capacity to hydrolyse cytosolic TAG and to transfer the product fatty acids into the microsomal membrane PL, probably via acylation of a lysophospholipid component. In an attempt to reconcile observations such as this with the apparent requirement for the lipolytic transfer of cytosolic TAG into VLDL TAG, we have previously proposed a scheme in which cytosolic TAG fatty acids are 
Concluding remarks
The studies described above, together with previously reported studies of PL and diacylglycerol turnover and transport [33, 37] and PL remodelling [38] [39] [40] strongly suggest that the lipid enzymology of VLDL assembly is probably far more complex than is apparent from the simple scheme shown in Figure 1 . Although this diagram summarizes our current understanding, it remains, at present, simply an empirical statement of VLDL assemblythe beginning and the end of a complex process. What happens in between is mainly a question of guesswork and probably involves subtle, and, as yet, undiscovered metabolic transformations in the secretory apparatus of the cell.
If we are ever to understand the regulation of VLDL secretion, and all that this implies for the control of plasma lipid levels, it is essential that we focus some of our research effort on the enzymology of intrahepatic lipid recruitment and how this is co-ordinated with apoB translocation. This is a research area in which the techniques of metabolic biochemistry coupled with those of cell and molecular biology are poised to pay rich dividends with important implications for the control of hepatic lipid balance. 
